Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel, allogeneic, "off the shelf", cell therapies for serious medical conditions, ...

Suniva Completes $835 Million Capital Raise to Build Second Major U.S. Solar Cell Manufacturing Facility and More Than Quadruple Capacity to 5.5 GW ...

IMTS 2026 showcases automation, additive manufacturing and AI helping U.S. laboratories rapidly develop critical technologies ...

A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s Cellares has passed another major production milestone. Cellares’ automated ...

It's an exciting time to be in cell therapy manufacturing and commercialization, particularly in the oncology space. This year alone, we've seen the US approval of three cell therapy products: Iovance ...

CEO Graeme Purdy spoke with Proactive's Stephen Gunnion about the latest progress with the company's Goliath battery ...

Suniva has raised US$835 million to support the development of a new 4.5GW cell manufacturing facility in South Carolina.

Swedish solar energy specialist Midsummer AB has signed a binding investment and industrialisation framework agreement with ...

Advances in media optimization, cell engineering, and AI are reshaping intensified bioprocessing for higher productivity, better quality, and greater manufacturing efficiency.

Cell and gene therapies are expected to become increasingly important treatment options for cancer and other intractable diseases.